The global canine influenza vaccine market is estimated to be valued at USD 1,901.6 Mn in 2025, and is expected to reach USD 2,731.5 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.
To learn more about this report, Request sample copy
Increasing pet adoption and rising awareness about animal health is expected to fuel the demand for canine influenza vaccines. Additionally, growth in R&D activities to develop effective and novel vaccines and rising government support for pet immunization will further aid market expansion. Vaccination has become an important practice to control the spread of canine influenza virus among the pet dog population. Wide distribution network of key players ensures broad availability and accessibility of vaccines which is also supporting the market growth.
Increasing Animal Healthcare Expenditure
Increasing animal healthcare expenditure is expected to drive the global canine influenza vaccine market growth over the forecast period. For instance, in May 2023, the North American Pet Health Insurance Association (NAPHIA) released its 2023 State of the Industry (SOI) report, indicating that the North American pet health insurance sector grew by 23.5% in In-Force GWP over 2022.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients